A-PVP
α-pyrrolidinopentiophenone
Standing risks
- High overdose risk, use cautionconfidence medium
- Acute toxicity
- high
- Compulsive use risk, monitor frequencyconfidence high
- Compulsive redosing
- high
- Dose escalation
- high
- High dependence, taper carefullyconfidence high
- Physical dependence
- low
- Psychological dependence
- high
Lethal interactions
Specific substances
- Tramadollethal
By drug class
- Ibogainelethal3 mechanismsconfidence medium
Dangerous interactions
29 dangerous interactions recorded for this substance.
See the full interactions tableContraindications
Cardiovascular
- coronary artery diseaseabsolute
α-PVP's sympathomimetic cardiovascular effects place dangerous demand on compromised coronary vasculature. Fatal cardiovascular collapse is documented in the sympathomimetic toxidrome.
- uncontrolled hypertensionabsolute
Additive pressure elevation risks hypertensive crisis, stroke, or aortic dissection.
- cardiac arrhythmiasabsolute
Pre-existing arrhythmias are exacerbated by sympathomimetic cardiac effects. Cardiac monitoring is standard in toxicity management.
Neurological
- epilepsyrelative
Individuals with epilepsy or other seizure disorders face elevated risk of drug-induced seizures.
Psychiatric
- psychotic disordersabsolute
α-PVP is strongly associated with acute psychosis, paranoid ideation, hallucinations, and aggressive behavior. Extreme risk of symptom exacerbation in individuals with schizophrenia or schizoaffective disorder.
- bipolar disorderabsolute
Intense dopaminergic activation risks precipitating mania or psychotic mania in individuals with bipolar disorder.
Renal
- chronic kidney diseaserelative
Pre-existing renal impairment reduces capacity to handle myoglobin load and catecholamine-mediated vasoconstriction.
Pregnancy & Breastfeeding
- pregnancy and breastfeedingabsolute
No reproductive toxicology data exist for α-PVP. Absolute contraindication by precautionary principle based on sympathomimetic pharmacology.